Liz Galle - Jan 18, 2023 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role
VP OF GLOBAL CLINICAL RESEARCH
Signature
/s/ Amy C. Seidel, Attorney-in-Fact
Stock symbol
CVRX
Transactions as of
Jan 18, 2023
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 06:14 PM
Previous filing
Aug 4, 2022
Next filing
Oct 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Stock Option (right to buy) Award $0 +26K $0.00 26K Jan 18, 2023 Common Stock 26K $15.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter.